Kestra Medical Risk Adjusted Performance
| KMTS Stock | | | 19.56 -0.02 -0.10% |
Observed values used in the Risk Adjusted Performance indicator for Kestra Medical Technologies are included in this dataset. The information is based on observed market data across timeframes. Data coverage may vary across sources and reporting intervals. Comparable indicator datasets are structured within
Equity Screeners. Kestra Medical has a market cap of 1.14 B, operating margin of -140.73%, ROE of -126.4%. See
Correlation Analysis for additional portfolio context. The allocation summary reflects available position data. Portfolio metrics are derived from available position data. A position in Kestra Medical Technologies is indicated here. It is reflected in the overall portfolio structure. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as
signals in real.
Kestra Medical Technologies has current Risk Adjusted Performance of
-0.07.
RAP | = | (ER[a] - RFR) * STD[b])/STD[b]RFR |
| = | -0.07 | |
Risk Adjusted Performance Peers Comparison
Risk Adjusted Performance Relative To Other Indicators
Kestra Medical Technologies is rated
below average in risk adjusted performance relative to competitors. It is currently under evaluation in maximum drawdown relative to competitors .
Other Technical Indicators